Browse studies

Find your next paid study

841 recruiting studies matching your filters

A Phase I/II Study of Azacitidine, Venetoclax, and Gilteritinib for Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome With an Activating FLT3 Mutation

This phase I/II trial studies the side effects and best dose of gilteritinib and to see how well it works in combination with azacitidine and venetoclax in tre…

Recurrent Acute Myeloid LeukemiaRecurrent Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic/Myeloproliferative Neoplasm+3 more

Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT04140487

Phase 1

Adaptive Radiation for Abdominopelvic Metastases (ARAM)

Single arm Phase I trial of adaptive stereotactic body radiation (SBRT) for abdominopelvic metastases. Adaptive SBRT will allow for escalation of the prescript…

Neoplasm - Soft Tissue Pelvis Malignant SecondaryMalignant Neoplasm of Stomach

Estimated

~$10 – $6,250

Fox Chase Cancer CenterNCT05880667

Integration of Machine Learning and Genomics to Predict Outcomes for Newly Diagnosed, Relapsed and Refractory Mature T-cell and NK/T-cell Lymphomas: a Global Study of the PETAL Consortium

The goal of this observational study is to correlate molecular alterations with outcomes including overall survival (OS), progression-free survival (PFS), resp…

T-Cell and NK-Cell Neoplasm

Estimated

~$10 – $750

Massachusetts General HospitalNCT06067347

Phase 1

A Modular Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of AZD2962, an IRAK4 Inhibitor, as Monotherapy and in Combination With Other Agents, in Participants With Haematologic Neoplasms

The purpose of the study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD2962, an Interleukin-1 R…

Haematologic Neoplasms

Estimated

~$10 – $7,500

AstraZenecaNCT07064122

Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

This study evaluates patient perceptions around quality of care through telemedicine in neuro-oncology. Studying questionnaires related to perceptions quality …

Central Nervous System NeoplasmLeptomeningeal NeoplasmMetastatic Malignant Neoplasm in the Brain+1 more

Estimated

~$10 – $750

M.D. Anderson Cancer CenterNCT04988009

Observational

Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HC…

Cognitive ImpairmentHematologic NeoplasmsHematopoietic Cell Transplant

Estimated

~$10 – $6,250

University of Alabama at BirminghamNCT03094026

Observational

Randomized Controlled Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy

Subjects will be randomized into 2 groups (stent or no stent) prior to radical cystectomy with ileal conduit urinary diversion (RCIC). They will follow the sta…

Bladder CancerMuscle-Invasive Bladder CarcinomaUrothelial Carcinoma+3 more

Estimated

~$10 – $6,250

Thomas Jefferson UniversityNCT07234968

Phase 2

MC251001 - Phase II Randomized Double-Blinded Pilot Study of THC vs. THC/CBD (1:1) vs. Placebo for Insomnia in Patients With Cancer

This phase II trial compares THC versus (vs.) THC with CBD vs. placebo to improve sleep quality for patients with solid organ cancer and insomnia. Many patient…

InsomniaMalignant Solid Neoplasm

Estimated

~$10 – $6,250

Mayo ClinicNCT07565974

Phase 2

A Phase II Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)

This phase II trial tests how well ibrutinib works in preventing chronic graft-versus-host disease (GVHD) in patients undergoing donor (allogeneic) hematopoiet…

Chronic Graft Versus Host DiseaseHematopoietic and Lymphatic System Neoplasm

Estimated

~$10 – $6,250

Mayo ClinicNCT06271616

Observational

mHealth App for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

This clinical trial assesses the impact of a family caregiver-delivered massage technique for use in cancer survivors with chemotherapy-induced peripheral neur…

Chemotherapy-Induced Peripheral NeuropathyMalignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm

Estimated

~$10 – $6,250

Mayo ClinicNCT06945380

UWCCC Precision Medicine Molecular Tumor Board Registry

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Hematologic NeoplasmsSolid Neoplasm

Estimated

~$10 – $750

University of Wisconsin, MadisonNCT03023202

Phase 2

An Investigation in the Use of Curcumin Topical Herbal Agent for the Treatment of Cervical Intraepithelial Neoplasia

The purpose of this study is to see if curcumin can suppress HPV infection in women with low-grade squamous intraepithelial lesions (LSIL) disease or treated h…

Neoplasm Cervix

Estimated

~$10 – $7,500

Lisa FlowersNCT04266275